An Exploratory Investigation to Identify if Dame Product's "DLM" Works to Improve Sexual Desire and Mood in Females

Dame Products, Inc.55 enrolled

Overview

This is a single-group, non-randomized, non-controlled, open-label observational trial to study and evaluate the efficacy of a commercial dietary supplement, called "DLM" ("test product"). It is hypothesized that the test product, which is designed as an edible gummy, will present a favorable result to increase sexual desire and improve mood.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Sexual Desire Disorder

Interventions

DLM - Test productDIETARY_SUPPLEMENT

The group will receive 60 gummies each (to take two gummies per day) across a four-week period. Each participant shall take two gummies per day

Eligibility

Sex: FEMALEMin age: 24 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Females between 24-65 of age * Must be in good health (don't report any medical conditions asked in the screening questionnaire) * Experience sexuality-related personal distress (established in an online-screening questionnaire) * Experience a regular menstrual cycle * In the subject's opinion, previously experienced "normal sexual desire" * Self-reported stress in their daily lives * My present with self-reported anxiety * Trouble being present in the moment * Consider themselves as being busy all the time Exclusion Criteria: * Current urinary or vaginal infection * Vaginal prolapse and any other disease that could interfere with the study conduction and participation * Diagnosis of depression * Diagnosis of anxiety * Currently experiencing significant symptoms of a mental disorder that might interfere with study participation (e.g. eating disorder, obsessive-compulsive disorder, posttraumatic stress syndrome, bipolar disorder) * Current substance abuse disorder * Diagnosis of an autoimmune disease, such as multiples sclerosis and rheumatoid arthritis * Self-reported or diagnosed hypotension (BP \< 90 over 60) * Is currently using, or has used any of the following types of medication within 6 months of screening: Any for of antidepressants; Mood stabilizers Benzodiazepines ("tranquillizers") Cognitive enhancers or stimulants (e.g. Adderall) The following contraception: Hormonal combination birth control pill; hormonal progesterone-only birth control pill; birth control patch; NuvaRing; Nexplanon Taking insulin or other diabetes medication * Currently, or in the past 6 months, undergoing hormone therapy * Any medical condition that is unstable or uncontrolled * A history of sexual trauma or abuse * Females that are pregnant, want to become pregnant for the duration of the study, or who are breastfeeding

Locations (1)

Citruslabs

Santa Monica, California, United States

Outcomes

Primary Outcomes

Increase in sexual desire in women and associated improvements of mood and quality of life. [Time Frame: Baseline to 4 weeks)

Survey-based assessment (0-5 scale with 0 being the lowest possible score and 5 being the highest) of changes in sexual desire, mood, and quality of life between baseline and study intervention period.

Time frame: 4 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.